-
Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population
Mar 10, 2025, 14:00 PM -
Current Evidence and Research Gaps on the Economic Burden of Graves' Disease: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan
Mar 10, 2025, 14:00 PM -
Adapting Global Cost-Effectiveness Models for Low- and Middle-Income Countries: Key Learnings and Challenges Addressed
Mar 10, 2025, 14:00 PM -
The Global Economic Burden of Type 1 Diabetes: Current Estimates and Projections to 2040
Mar 10, 2025, 14:00 PM -
Challenges in Projecting Treatment Journeys for ALK-mutated NSCLC: Addressing Uncertainty in PPS and Immature Overall Survival Data
Mar 10, 2025, 14:00 PM -
Changes in HbA1c and Body Weight in US Adults With Type 2 Diabetes and Chronic Kidney Disease Who Received Oral Semaglutide
Mar 10, 2025, 14:00 PM -
Hypertrophic Scar Severity and Clinical Management in the Real-World Dermatology Setting
Mar 10, 2025, 14:00 PM -
Disparities in Breast Cancer Screening Rates are Compounded by Type of Insurance Coverage and Social Drivers of Health
Mar 10, 2025, 14:00 PM -
Economic Savings Associated with Surgical Mitral Valve Replacement with a Novel Bovine Bioprosthesis
Mar 10, 2025, 14:00 PM -
The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada
Mar 10, 2025, 14:00 PM -
Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life (HRQoL) of Large B-cell Lymphoma (LBCL) and Follicular Lymphoma (FL) Patients Treated with Axicabtagene Ciloleucel (Axi-cel) in Clinical Trials and the Real-World: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States.
Mar 10, 2025, 14:00 PM -
Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mar 10, 2025, 14:00 PM -
Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (<7.5mg) across 1.5 Years
Mar 10, 2025, 14:00 PM -
Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)
Mar 10, 2025, 14:00 PM -
Youth Mental Health Crisis: Economic Impacts and HEOR Opportunities
Mar 10, 2025, 14:00 PM -
Analysis of Disease Progression in 769 Patients With Dominant Alport Syndrome
Mar 10, 2025, 14:00 PM -
Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans
Mar 10, 2025, 14:00 PM
